Literature DB >> 7171483

Long term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal.

L Fry, J N Leonard, F Swain, W F Tucker, G Haffenden, N Ring, R M McMinn.   

Abstract

Seventy-eight patients with dermatitis herpetiformis have been followed up for periods ranging from 3 to 14 years (mean 7.4). Forty-two patients were treated with gluten-free diet (GFD) and thirty-six took a normal diet (ND). Thirty of the forty-two (71%) taking the GFD were able to discontinue drugs previously needed to control their rash compared with five (14%) of the thirty-six patients taking a ND. The mean time taken to reduce drug requirements for patients taking a GFD was 8 months (range 4-30), and for stopping drugs, 29 months (range 6-108). The incidence of macroscopic abnormality of the small intestine decreased from 69 to 15%, and the mean intra-epithelial lymphocyte count decreased significantly in those patients taking a GFD, whereas there was no significant change in patients taking a ND. The improvement in the skin and intestinal lesions was related to the strictness of the GFD.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7171483     DOI: 10.1111/j.1365-2133.1982.tb00520.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  15 in total

1.  The changing face of celiac disease.

Authors:  R Lad; K Jacobson
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

2.  Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy.

Authors:  A D Smith; B Bagheri; R D Streilein; R P Hall
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

Review 3.  The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis.

Authors:  Carolina Ciacci; Paul Ciclitira; Marios Hadjivassiliou; Katri Kaukinen; Jonas F Ludvigsson; Norma McGough; David S Sanders; Jeremy Woodward; Jonathan N Leonard; Gillian L Swift
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

4.  Foods for patients with dermatitis herpetiformis (correction)

Authors: 
Journal:  Can Med Assoc J       Date:  1983-05-15       Impact factor: 8.262

5.  Increased production of IL-4 by gut T-cell lines from patients with dermatitis herpetiformis compared to patients with isolated gluten-sensitive enteropathy.

Authors:  R P Hall; A D Smith; R D Streilein
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

6.  Small intestinal function and dietary status in dermatitis herpetiformis.

Authors:  D J Gawkrodger; C McDonald; S O'Mahony; A Ferguson
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

7.  Dermatitis herpetiformis and growth retardation.

Authors:  U Kuhnle; R Bertele-Harms; A Grösser; M Meurer
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

8.  Dermatitis herpetiformis: diagnosis, diet and demography.

Authors:  D J Gawkrodger; J N Blackwell; H M Gilmour; E A Rifkind; R C Heading; R S Barnetson
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

9.  Gluten challenge in children with dermatitis herpetiformis: a clinical, morphological and immunohistological study.

Authors:  I Kósnai; S Kárpati; E Savilahti; M Verkasalo; P Bucsky; E Török
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

10.  Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet.

Authors:  T Reunala; I Kosnai; S Karpati; P Kuitunen; E Török; E Savilahti
Journal:  Arch Dis Child       Date:  1984-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.